07:30-08:15
Satellite Symposium 3:

Novartis Korea Ltd.

Room 1 (Vista 1+2)
08:30-09:45
Symposium 5:

Biomarker-Driven Adaptive Surgery in the Era of Neoadjuvant Therapy

Room 1 (Vista 1+2)
Panel Discussion 4:

Current Landscapes and Future Prospectives of HER2 low/ultralow Breast Cancer

Room 2 (Grand 1)
Symposium 6:

AI Across Breast Imaging

Room 3 (Walker 1)
Nursing Session 1 (Kor.):

From Surgery to Systemic Therapy: Managing Physical Complication in Breast Cancer Care

Room 4 (Walker 2)
GBCC-JBCS-TBCS Joint Session:

Current Evidence of Ovarian Function Suppression and Real-World Practice in Asia

Room 5 (Art Hall)
10:00-11:15
General Session 2

Room 1 (Vista 1+2)
Multidisciplinary Session:

Integrating AI into Cancer Treatment

Room 2 (Grand 1)
Education Session 2:

Modern Axillary Care in Breast Cancer: Integrating Surgical, Imaging and Pathologic Insights

Room 3 (Walker 1)
Nursing Session 2 (Kor.):

Unmet Needs and Holistic Care in Patient with Metastatic or Recurrent Breast Cancer

Room 4 (Walker 2)
Mini Oral Presentation 3

Room 5 (Art Hall)
11:30-12:15
Plenary Lecture 3:

Next Generation ADCs

Room 1 (Vista 1+2)
12:30-13:15
Satellite Symposium 4:

Daiichi-Sankyo Korea

Room 1 (Vista 1+2)
Satellite Symposium 5:

Roche Korea co.,ltd

Room 2 (Grand 1)
13:30-14:15
Plenary Lecture 4:

What Does it Take to Make Precision Oncology Precise?

Room 1 (Vista 1+2)
14:30-15:20
Junior Doctors Forum

Room 4 (Walker 2)
14:30-15:45
Symposium 7:

Evolving Landscape of HR+/HER2- Metastatic Breast Cancer Treatment

Room 1 (Vista 1+2)
Panel Discussion 5:

Modern Axillary Management in Breast Cancer with Regional Nodal Involvement

Room 2 (Grand 1)
Education Session 3:

Breast Cancer Related Lymphedema: Etiologic Factors and Risk Stratification

Room 3 (Walker 1)
Mini Oral Presentation 4

Room 5 (Art Hall)
15:35-17:15
Junior Doctors Debate

Room 4 (Walker 2)
16:00-17:15
Symposium 8:

De-escalation of Breast Cancer Surgery: What We Know vs. What We Actually Do

Room 1 (Vista 1+2)
Symposium 9:

Shaping the Future of Breast Cancer Treatment with Antibody Drug Conjugates

Room 2 (Grand 1)
Education Session 4:

Locoregional Management for Lymph Node Positive Breast Cancer

Room 3 (Walker 1)
Education Session 5:

Enhancing and Optimizing Survivorship Throughout Cancer Treatment

Room 5 (Art Hall)